Jennifer Kissner

Title: Innovations by Jennifer Kissner in Ocular Disease Treatment

Introduction

Jennifer Kissner is an accomplished inventor based in Alpharetta, GA (US). She has made significant contributions to the field of ocular medicine, particularly in the treatment of ocular diseases. Her innovative approach focuses on non-surgical methods for drug administration, which has the potential to improve patient outcomes.

Latest Patents

Jennifer Kissner holds 1 patent for her work titled "Methods and devices for the treatment of ocular diseases in human subjects." This patent describes methods and devices for targeted non-surgical administration of a drug formulation to the suprachoroidal space (SCS) of the eye. The invention aims to treat posterior ocular disorders or choroidal maladies. One embodiment of her method involves inserting a hollow microneedle into the eye at an insertion site and infusing a drug formulation through the microneedle into the suprachoroidal space. The infused drug formulation is designed to flow within the suprachoroidal space away from the insertion site during the infusion process. Additionally, the fluid drug formulation may comprise drug nanoparticles or microparticles.

Career Highlights

Jennifer Kissner is currently associated with Clearside Biomedical, Inc., where she continues to advance her research and development efforts. Her work is pivotal in the ongoing quest to enhance treatment options for patients suffering from ocular diseases.

Collaborations

Jennifer collaborates with notable professionals in her field, including Vladimir Zarnitsyn and Samirkumar Rajnikant Patel. These collaborations contribute to the innovative environment at Clearside Biomedical, Inc.

Conclusion

Jennifer Kissner's contributions to ocular disease treatment through her innovative patent demonstrate her commitment to improving healthcare solutions. Her work exemplifies the impact of targeted drug delivery methods in enhancing patient care.